Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?. Issue 1 (17th July 2013)

• Record Type: Journal Article
• Authors: Decroos, Emily Choi; Hobson‐Webb, Lisa D.; Juel, Vern C.; Massey, Janice M.; Sanders, Donald B.
• Is Part Of: Muscle & nerve. Volume 49:Issue 1(2014:Jan.)
• Page Start: 30
• Page End: 34
• Publication Date: 2013-07-17
• Subjects: Neuromuscular diseases -- Periodicals; Muscles -- Periodicals; Nerves -- Periodicals; 616.74
• DOI: 10.1002/mus.23882
• Languages: English
• ISSNs: 0148-639X

Abstract

<abstract abstract-type="main"> <title>ABSTRACT</title> <p> <italic>Introduction</italic>: Acetylcholine receptor (AChR) and striated muscle antibodies (StrAbs) are found frequently in myasthenia gravis (MG) patients with thymoma. In this study we aimed to determine the positive predictive value (PPV) and negative predictive value (NPV) of these antibodies for thymoma in patients with MG. <italic>Methods</italic>: Antibody findings, thymic histology, and onset age were reviewed for 1141 patients with MG. PPV and NPV of these antibodies for thymoma were determined. <italic>Results</italic>: The PPV of AChR binding antibodies plus StrAbs was highest (50.0%) with onset before the age of 40 years. The PPV of all antibodies was low (&lt;9%) after age 40. Higher StrAb levels did not increase the PPV. The NPV of AChR binding antibodies was high (99.7%) for all ages. <italic>Conclusions</italic>: Patients without AChR binding antibody are not likely to have a thymoma. StrAbs and AChR binding antibodies are not diagnostic for thymoma, but in early‐onset MG their presence should raise the clinical suspicion for thymoma. <italic>Muscle Nerve</italic><bold>49</bold>: 30–34, 2014</p> </abstract>